791 related articles for article (PubMed ID: 25296739)
21. Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.
Moore A; Green LJ; Bruce S; Sadick N; Tschen E; Werschler P; Cook-Bolden FE; Dhawan SS; Forsha D; Gold MH; Guenthner S; Kempers SE; Kircik LH; Parish JL; Rendon MI; Rich P; Stein-Gold L; Tyring SK; Weiss RA; Nasir A; Schmitz C; Boodhoo TI; Kaoukhov A; Berk DR
J Drugs Dermatol; 2018 Sep; 17(9):987-996. PubMed ID: 30235387
[TBL] [Abstract][Full Text] [Related]
22. Effect of adapalene 0.1%/benzoyl peroxide 2.5% topical gel on quality of life and treatment adherence during long-term application in patients with predominantly moderate acne with or without concomitant medication - additional results from the non-interventional cohort study ELANG.
Gollnick HP; Friedrich M; Peschen M; Pettker R; Pier A; Streit V; Jöstingmeyer P; Porombka D; Rojo Pulido I; Jäckel A
J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 4():23-9. PubMed ID: 26059731
[TBL] [Abstract][Full Text] [Related]
23. Post-adolescent acne: a review of clinical features.
Goulden V; Clark SM; Cunliffe WJ
Br J Dermatol; 1997 Jan; 136(1):66-70. PubMed ID: 9039297
[TBL] [Abstract][Full Text] [Related]
24. Predictive markers of response to isotretinoin in female acne.
Preneau S; Dessinioti C; Nguyen JM; Katsambas A; Dreno B
Eur J Dermatol; 2013; 23(4):478-86. PubMed ID: 23797561
[TBL] [Abstract][Full Text] [Related]
25. Effects of skin care and makeup under instructions from dermatologists on the quality of life of female patients with acne vulgaris.
Matsuoka Y; Yoneda K; Sadahira C; Katsuura J; Moriue T; Kubota Y
J Dermatol; 2006 Nov; 33(11):745-52. PubMed ID: 17073988
[TBL] [Abstract][Full Text] [Related]
26. A multicenter epidemiological study of acne vulgaris in Korea.
Suh DH; Kim BY; Min SU; Lee DH; Yoon MY; Kim NI; Kye YC; Lee ES; Ro YS; Kim KJ
Int J Dermatol; 2011 Jun; 50(6):673-81. PubMed ID: 21595660
[TBL] [Abstract][Full Text] [Related]
27. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation.
Abad-Casintahan F; Chow SK; Goh CL; Kubba R; Hayashi N; Noppakun N; See J; Suh DH; Xiang LH; Kang S;
J Dermatol; 2016 Jul; 43(7):826-8. PubMed ID: 26813513
[TBL] [Abstract][Full Text] [Related]
28. A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium.
Leyden JJ; Bruce S; Lee CS; Ling M; Sheth PB; Stewart DM; Werschler WP; Gilbert RD; Kircik L
J Drugs Dermatol; 2013 Jun; 12(6):658-63. PubMed ID: 23839182
[TBL] [Abstract][Full Text] [Related]
29. A Randomized Controlled Study of a Novel Botanical Acne Spot Treatment.
Barak-Shinar D; Draelos ZD
J Drugs Dermatol; 2017 Jun; 16(6):599-603. PubMed ID: 28686778
[TBL] [Abstract][Full Text] [Related]
30. The Clinical and Epidemiological Profile of Adult Female Acne Vulgaris in Lagos, Nigeria.
Anaba EL; Oaku IR
West Afr J Med; 2021 Aug; 38(8):785-790. PubMed ID: 34505184
[TBL] [Abstract][Full Text] [Related]
31. Novel facial cosmetic area 'O zone' shows unique characteristics in sebum excretion and acne lesion distribution.
Youn SH; Choi CW; Choi JW; Kim BR; Byun SY; Youn SW
Skin Res Technol; 2014 May; 20(2):164-9. PubMed ID: 23981080
[TBL] [Abstract][Full Text] [Related]
32. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
Langner A; Chu A; Goulden V; Ambroziak M
Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
[TBL] [Abstract][Full Text] [Related]
33. A brief primer on acne therapy for adolescents with skin of color.
Silverberg NB
Cutis; 2013 Jul; 92(1):20-6. PubMed ID: 23961520
[TBL] [Abstract][Full Text] [Related]
34. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
Guerra-Tapia A
J Drugs Dermatol; 2012 Jun; 11(6):714-22. PubMed ID: 22648218
[TBL] [Abstract][Full Text] [Related]
35. Acne vulgaris and depression: a retrospective examination.
Uhlenhake E; Yentzer BA; Feldman SR
J Cosmet Dermatol; 2010 Mar; 9(1):59-63. PubMed ID: 20367674
[TBL] [Abstract][Full Text] [Related]
36. Epidemiologic, clinical, and therapeutic features of acne in Dakar, Senegal.
Kane A; Niang SO; Diagne AC; Ly F; Ndiaye B
Int J Dermatol; 2007 Oct; 46 Suppl 1():36-8. PubMed ID: 17919205
[TBL] [Abstract][Full Text] [Related]
37. Multimodal treatment of acne, acne scars and pigmentation.
Shamban AT; Narurkar VA
Dermatol Clin; 2009 Oct; 27(4):459-71, vi. PubMed ID: 19850195
[TBL] [Abstract][Full Text] [Related]
38. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.
Webster GF; Guenther L; Poulin YP; Solomon BA; Loven K; Lee J
Cutis; 2002 Feb; 69(2 Suppl):4-11. PubMed ID: 12095066
[TBL] [Abstract][Full Text] [Related]
39. Validation of the Spanish Acne Severity Scale (Escala de Gravedad del Acné Española--EGAE).
Puig L; Guerra-Tapia A; Conejo-Mir J; Toribio J; Berasategui C; Zsolt I
Eur J Dermatol; 2013 Apr; 23(2):233-40. PubMed ID: 23608147
[TBL] [Abstract][Full Text] [Related]
40. Multimodal Clinical Imaging Assessment of the Outcome in Mild-to-Moderate Acne: A Prospective Study.
Kyrgidis A; Becker M; Zampeli V; Fauger A; Sayag M; Zouboulis CC
Dermatology; 2019; 235(6):471-477. PubMed ID: 31390623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
